Crunchy Caramel artisan dark chocolate with crunch brown sugar caramel pieces 60% Cacao, NET WT 2 oz (60g), Ingredients *Cocoa Butter, Soy Lecithin (Emulsifier), Butter (Cream, Natural Flavor) CONTAINS: SOY. Garcia Nevett chocolatier de miami, packaged in plastic envelope inside paper envelope, 10 bars per box.
Crunchy Caramel artisan dark chocolate from Cacao Art was recalled because milk was not declared as an allergen. FDA enforcement record H-0498-2026 is terminated as of 2026-06-09; check the exact product and lot details before relying on older active-recall notices.
By RecallRadar Editorial Team
Sourced from FDA. Last verified March 15, 2026.
On this page
Free checker
Check if you qualify
See whether your device may qualify for a free repair or replacement program before you spend money.
Check if you qualifyKey facts
- Date announced
- February 18, 2026
- Source agency
- FDA
This recall involves safety concerns. Take action promptly.
✨ Plain-English Summary
Crunchy Caramel artisan dark chocolate from Cacao Art was recalled because milk was not declared as an allergen. FDA enforcement record H-0498-2026 is terminated as of 2026-06-09; check the exact product and lot details before relying on older active-recall notices.
Is This Recall Still Active?
Status: No - Expired
This recall is no longer active. You can still review details here for historical reference and confirmation.
What's Being Recalled
Quoted source excerpt from the official notice.
Undeclared allergen - milk. Product contains butter; cream is listed as a sub-ingredient of the butter, but milk is not declared in the ingredients or a contains statement.
Quick Info
Key facts from the official notice, kept in the article flow for easy cross-checking.
- Brand
- Cacao art
- Category
- food
- Source agency
- FDA
- Announced
- February 18, 2026
- Expires
- June 9, 2026
- Country
- US
- Status
- Expired
Who's Affected
Specific models and identifiers listed in the source notice:
Model #1
EXP 07 2026
| # | Model |
|---|---|
| 1 | EXP 07 2026 |
Technical model codes are manufacturer identifiers. Match both the product name and model code from your device settings, label, or packaging.
What You Should Do
Follow the remedy path from the official notice using the exact model and serial details above.
- 1Stop using the affected product until you verify whether your item is impacted.
- 2Check the official recall notice and match your model, lot, or serial details.
- 3Follow the official instructions for repair, replacement, refund, or disposal.
This program has ended. The official source page may no longer be available.
Source & Verification
This page summarizes the official notice and keeps key facts easy to verify.
- Official source
- FDA
- Announced by source
- February 18, 2026
- Last reviewed by RecallRadar
- March 15, 2026
Frequently Asked Questions
Am I affected by this recall?
Check the affected models section on this page. The official notice currently lists EXP 07 2026.
What is the remedy for this recall?
Follow the official instructions for repair, replacement, refund, or disposal on the cacao art recall page.
Where can I verify recall details?
Use the official source link in this page to confirm dates, eligibility, and next steps: https://api.fda.gov/food/enforcement.json?search=recall_number.exact:%22H-0498-2026%22&limit=1
Keep browsing with these internal hubs: cacao art recall hub and Food & Drug recall hub.
Official Resources
Use these primary sources for final eligibility and claim instructions.
View official notice from FDASee an inaccuracy?
Help us improve the accuracy of this recall information.
On this page
Free checker
Check if you qualify
See whether your device may qualify for a free repair or replacement program before you spend money.
Check if you qualifyKey facts
- Date announced
- February 18, 2026
- Source agency
- FDA
Related Recalls
Clobetasol Propionate Cream USP, 0.05%, 60 g tube, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Pithampur (MP) 454 775, INDIA, NDC 68180-956-04.
Failed content uniformity specifications.
Sep 2, 2026
Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-453-17.
Subpotent Drug
Sep 2, 2026
Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 & NDC 63004-8710-2
Presence of particulate matter: glass and stopper piece
Sep 2, 2026
Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-448-17.
Subpotent Drug
Sep 2, 2026
Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, Illinois, 60047, NDC 65219-594-20.
Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.
Sep 2, 2026